BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 21320609)

  • 1. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
    Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
    Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine.
    Gulyas B; Toth M; Vas A; Shchukin E; Kostulas K; Hillert J; Halldin C
    Curr Radiopharm; 2012 Jan; 5(1):19-28. PubMed ID: 22074478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine.
    Gulyás B; Tóth M; Schain M; Airaksinen A; Vas A; Kostulas K; Lindström P; Hillert J; Halldin C
    J Neurol Sci; 2012 Sep; 320(1-2):110-7. PubMed ID: 22841414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [
    Deussing M; Blume T; Vomacka L; Mahler C; Focke C; Todica A; Unterrainer M; Albert NL; Lindner S; von Ungern-Sternberg B; Baumann K; Zwergal A; Bartenstein P; Herms J; Rominger A; Brendel M
    Neuroimage; 2018 Jan; 165():83-91. PubMed ID: 28988133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies.
    Gulyás B; Halldin C; Vas A; Banati RB; Shchukin E; Finnema S; Tarkainen J; Tihanyi K; Szilágyi G; Farde L
    J Neurol Sci; 2005 Mar; 229-230():219-23. PubMed ID: 15760643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
    Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
    Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
    Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [
    Tan Z; Haider A; Zhang S; Chen J; Wei J; Liao K; Li G; Wei H; Dong C; Ran W; Li Y; Li Y; Rong J; Li Y; Liang SH; Xu H; Wang L
    Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
    Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
    J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.
    Gulyás B; Makkai B; Kása P; Gulya K; Bakota L; Várszegi S; Beliczai Z; Andersson J; Csiba L; Thiele A; Dyrks T; Suhara T; Suzuki K; Higuchi M; Halldin C
    Neurochem Int; 2009 Jan; 54(1):28-36. PubMed ID: 18984021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo
    Feng L; Jensen P; Thomsen G; Dyssegaard A; Svarer C; Knudsen LV; Møller K; Thomsen C; Mikkelsen JD; Guilloteau D; Knudsen GM; Pinborg LH
    J Nucl Med; 2017 Jun; 58(6):989-995. PubMed ID: 28572290
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
    Butler T; Wang X; Chiang G; Xi K; Niogi S; Glodzik L; Li Y; Razlighi QR; Zhou L; Hojjati SH; Ozsahin I; Mao X; Maloney T; Tanzi E; Rahmouni N; Tissot C; Lussier F; Shah S; Shungu D; Gupta A; De Leon M; Mozley PD; Pascoal TA; Rosa-Neto P
    J Alzheimers Dis; 2024; 99(1):307-319. PubMed ID: 38669537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography studies with [11C]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation.
    Tóth M; Doorduin J; Häggkvist J; Varrone A; Amini N; Halldin C; Gulyás B
    PLoS One; 2015; 10(5):e0125917. PubMed ID: 25996996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.
    Yasuno F; Kosaka J; Ota M; Higuchi M; Ito H; Fujimura Y; Nozaki S; Takahashi S; Mizukami K; Asada T; Suhara T
    Psychiatry Res; 2012 Jul; 203(1):67-74. PubMed ID: 22892349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.
    Xu J; Sun J; Perrin RJ; Mach RH; Bales KR; Morris JC; Benzinger TLS; Holtzman DM
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1423-1434. PubMed ID: 31402620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.